M Ungerer Selected Research

beta-Adrenergic Receptor Kinases

8/2003

Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Ungerer Research Topics

Disease

6	Heart Failure 06/2012 - 03/2000
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2001 - 03/2000
1	Ischemic Stroke 01/2020
1	Stroke (Strokes) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020

Drug/Important Bio-Agent (IBA)

2	Adrenergic Agents (Adrenergic Drugs)IBA 04/2001 - 03/2000
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	beta-Adrenergic Receptor KinasesIBA 08/2003
1	phosducinIBA 08/2003
1	beta-adrenergic receptor kinase inhibitory peptideIBA 08/2003
1	Carrier Proteins (Binding Protein)IBA 08/2003
1	CaspasesIBA 11/2001
1	CatecholaminesIBA 09/2001
1	beta Adrenergic ReceptorsIBA 04/2000
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 04/2000
1	Arginine Vasopressin (Argipressin)IBA 04/2000
1	Radioisotopes (Radionuclides)IBA 03/2000
1	CGP 12177IBA 03/2000
1	Mazindol (Mazanor)FDA Link 03/2000

Therapy/Procedure

2	Therapeutics 04/2000 - 03/2000